Article

Synthesis and properties of bioactive 2- and 3-amino-8-methyl-8H-quino[4,3,2-kl]acridine and 8,13-dimethyl-8H-quino[4,3,2-kl]acridinium salts.

Cancer Research Laboratories, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
Organic & Biomolecular Chemistry (impact factor: 3.7). 02/2004; 2(2):220-8. DOI:10.1039/b310796p pp.220-8
Source: PubMed

ABSTRACT Cyclisation of 9-(benzotriazol-1-yl)acridine to the pentacycle 8H-quino[4,3,2-kl]acridine in a range of low-boiling solvents is mechanistically distinct from previously published photochemical (carbene) and thermolytic (radical) cyclisations. Fragmentation of the triazole ring of to a diazonium intermediate, and its subsequent heterolysis (-N(2)) and cyclisation is facilitated by solvation of intermediate zwitterionic species. Derivatives of 2- and 3-aminoquinoacridines methylated in the 8-position can be converted to 8,13-dimethylquino[4,3,2-kl]acridinium iodide salts with methyl iodide and were required for biological examination as potential telomerase inhibitors. The chloro group in 3-chloro-8-methyl-8H-quino[4,3,2-kl]acridine can be replaced efficiently by benzylamino, 4-morpholinyl and cyano substituents in palladium(0) mediated reactions.

0 0
 · 
0 Bookmarks
 · 
16 Views
  • Source
    Article: Antitumor polycyclic acridines. 17. Synthesis and pharmaceutical profiles of pentacyclic acridinium salts designed to destabilize telomeric integrity.
    [show abstract] [hide abstract]
    ABSTRACT: Palladium(0)-mediated Suzuki-Miyaura and Heck transformations have been exploited to provide examples of 8-methylquino[4,3,2-kl]acridines and 8,13-dimethylquino[4,3,2-kl]acridinium iodides bearing bulky saturated (3-acetoxy)propyl or (E)-3-(morpholin-4-yl)-3-oxopropenyl substituents variously in the 3-, 6-, or 10-positions of the pentacyclic nucleus. The pharmacological/pharmaceutical properties of four compounds (4, RHPS4), (5, IH383), (6, RHPS16), and (17, RHPS19) were measured to assess their clinical potential as DNA G-quadruplex-stabilizing/telomerase inhibitory agents. The following properties were measured: stability in tissue culture media in the presence of A549 lung and MCF-7 breast tumor cells, metabolic stability when incubated with rat liver microsomes, and rate of uptake and subcellular location in A549 and MCF-7 cells. Compound 17 was unstable in tissue culture media, failed to achieve nuclear access, and was excluded from further consideration. Of the other agents, 4 exhibited the most favorable pharmaceutical profile: the agent has appropriate stability in the presence of tumor cells and rat liver microsomes and achieves rapid ingress into cell nuclei where the putative molecular target is located.
    Journal of Medicinal Chemistry 12/2005; 48(23):7198-207. · 5.25 Impact Factor

Full-text

View
0 Downloads
Available from

Keywords

3-aminoquinoacridines methylated
 
8,13-dimethylquino[4,3,2-kl]acridinium iodide salts
 
9-(benzotriazol-1-yl)acridine
 
biological examination
 
chloro group
 
Cyclisation
 
diazonium intermediate
 
intermediate zwitterionic species
 
low-boiling solvents
 
methyl iodide
 
palladium(0)
 
photochemical
 
potential telomerase inhibitors
 
radical
 

Ian Hutchinson